𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant human erythropoietin in chemotherapy-associated anemia

✍ Scribed by Stefano Cascinu; Giuseppina Catalano; Riccardo Cellerino


Book ID
116127819
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
995 KB
Volume
21
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Anemia associated with advanced prostati
✍ Beshara, Soheir; Letocha, Henry; Linde, TorbjΓΆrn; WikstrΓΆm, BjΓΆrn; Sandhagen, Bo πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 200 KB πŸ‘ 2 views

## BACKGROUND AND METHODS. Nine patients with hormone-refractory metastatic prostatic adenocarcinoma and anemia were treated with recombinant human erythropoietin (rHuEpo) at a median dose of 150 U/kg BW 3 times a week subcutaneously. Baseline hemoglobin (Hb) ranged from 70 to 116 g/L, and the stu

Recombinant erythropoietin in acute chem
✍ Beck, Maja Nenadov ;Beck, Daniel πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 444 KB

## Abstract Chemotherapy‐induced anemia in children with cancer is usually of acute onset. To investigate an alternate treatment to transfusion (Tx), we undertook a phase I‐II clinical trial of daily administrations of recombinant erythropoietin (rHuEPO). Patients with a hemoglobin (Hgb) value <75